Commentary: Using QbTest for monitoring pharmacological treatment response in ADHD – are we there yet?
Fuente:
Wiley Open Access
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Format: | Artículo Open Access |
| Veröffentlicht: |
Wiley
2024
|
| Schlagworte: | |
| Online-Zugang: | |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| _version_ | 1867018437683838976 |
|---|---|
| author | Alessio Bellato Valeria Parlatini Madeleine J. Groom Charlotte L. Hall Chris Hollis Emily Simonoff Anita Thapar Samuele Cortese |
| author_facet | Alessio Bellato Valeria Parlatini Madeleine J. Groom Charlotte L. Hall Chris Hollis Emily Simonoff Anita Thapar Samuele Cortese Alessio Bellato Valeria Parlatini Madeleine J. Groom Charlotte L. Hall Chris Hollis Emily Simonoff Anita Thapar Samuele Cortese |
| collection | Wiley Open Access |
| contents | Commentary: Using QbTest for monitoring pharmacological treatment response in ADHD – are we there yet? Alessio Bellato Valeria Parlatini Madeleine J. Groom Charlotte L. Hall Chris Hollis Emily Simonoff Anita Thapar Samuele Cortese Journal of Child Psychology and Psychiatry Individuals with attention‐deficit/hyperactivity disorder (ADHD) exhibit varied responses to pharmacological treatments (e.g. stimulants and non‐stimulants). Accurately and promptly detecting treatment‐related improvements, response failure, or deterioration poses significant challenges, as current monitoring primarily relies on subjective ratings. In this commentary, we critically evaluate the evidence supporting the use of QbTest for objectively monitoring ADHD treatment response in clinical practice. We also offer recommendations for future research, advocating for rigorous clinical trials and longitudinal studies to further explore the potential utilisation of QbTest and other tools for monitoring treatment responses in individuals with ADHD. 10.1111/jcpp.14071 http://creativecommons.org/licenses/by/4.0/ |
| doi_str_mv | 10.1111/jcpp.14071 |
| format | Artículo Open Access |
| id | wiley_oa_10_1111_jcpp_14071 |
| institution | Wiley Open Access |
| license_str_mv | http://creativecommons.org/licenses/by/4.0/ |
| publishDate | 2024 |
| publisher | Wiley |
| record_format | wiley_oa |
| spellingShingle | Commentary: Using QbTest for monitoring pharmacological treatment response in ADHD – are we there yet? Alessio Bellato Valeria Parlatini Madeleine J. Groom Charlotte L. Hall Chris Hollis Emily Simonoff Anita Thapar Samuele Cortese Journal of Child Psychology and Psychiatry Commentary: Using QbTest for monitoring pharmacological treatment response in ADHD – are we there yet? Alessio Bellato Valeria Parlatini Madeleine J. Groom Charlotte L. Hall Chris Hollis Emily Simonoff Anita Thapar Samuele Cortese Journal of Child Psychology and Psychiatry Individuals with attention‐deficit/hyperactivity disorder (ADHD) exhibit varied responses to pharmacological treatments (e.g. stimulants and non‐stimulants). Accurately and promptly detecting treatment‐related improvements, response failure, or deterioration poses significant challenges, as current monitoring primarily relies on subjective ratings. In this commentary, we critically evaluate the evidence supporting the use of QbTest for objectively monitoring ADHD treatment response in clinical practice. We also offer recommendations for future research, advocating for rigorous clinical trials and longitudinal studies to further explore the potential utilisation of QbTest and other tools for monitoring treatment responses in individuals with ADHD. 10.1111/jcpp.14071 http://creativecommons.org/licenses/by/4.0/ |
| title | Commentary: Using QbTest for monitoring pharmacological treatment response in ADHD – are we there yet? |
| topic | Journal of Child Psychology and Psychiatry |
| url | https://acamh.onlinelibrary.wiley.com/doi/10.1111/jcpp.14071 |